Literature DB >> 29079505

A constitutively-active IKK-complex at the axon initial segment.

Hans-Georg König1, Orla Watters2, Sinéad Kinsella3, Mohammed Ameen4, Beau J Fenner5, Jochen H M Prehn6.   

Abstract

BACKGROUND: Previous studies provided evidence for an accumulation of IκB-kinase (IKK) α/β at the axon initial segment (AIS), a neuronal compartment defined by ankyrin-G expression. Here we explored whether the presence of the IKK-complex at the AIS was associated with the activation of IKK signaling at this site. METHODS AND
RESULTS: Proximity-ligation assays (PLAs) using pan-IKKα/β, phospho-IKKα/β-specific as well as ankyrin-G specific antibodies validated their binding to proximal epitopes in the AIS, while antibodies to other phosphorylated signaling proteins showed no preference for the AIS. Small-hairpin mediated silencing of IKKβ significantly reduced anti-phospho-IKKα/β-immunoreactivities in the AIS. ank3 gene-deficient cerebellar Purkinje cells also exhibited no phosphorylated IKKα/β at the proximal region of their axons. Transient ankyrin-G overexpression in PC12 cells augmented NF-κB transactivation in an ankyrin-G death-domain dependent manner. Finally, small molecule inhibitors of IKK-activity, including Aspirin, inhibited the accumulation of activated IKK proteins in the AIS.
CONCLUSION: Our data suggest the existence of a constitutively-active IKK signaling complex in the AIS.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ankyrin-G; Axon; Axon initial segment; IKK 2 Kinase; NF-κB; Proximity ligation assay

Mesh:

Substances:

Year:  2017        PMID: 29079505     DOI: 10.1016/j.brainres.2017.10.020

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  1 in total

1.  Inhibition of AKT Signaling Alters βIV Spectrin Distribution at the AIS and Increases Neuronal Excitability.

Authors:  Jessica Di Re; Wei-Chun J Hsu; Cihan B Kayasandik; Nickolas Fularczyk; T F James; Miroslav N Nenov; Pooran Negi; Mate Marosi; Federico Scala; Saurabh Prasad; Demetrio Labate; Fernanda Laezza
Journal:  Front Mol Neurosci       Date:  2021-06-30       Impact factor: 5.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.